The PHLDA2 gene helps control how the placenta grows and how much support a baby receives before birth. This gene plays an important role in balancing fetal growth, and it is normally active mainly from the mother’s copy. If the PHLDA2 gene is too active or not active enough, the placenta may develop differently and a baby may be smaller or larger than expected at birth. Changes in this gene’s activity are also studied in some growth conditions linked to chromosome 11p15.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes hold the instructions for producing proteins, the parts of cells that do much of the work. Others mainly direct when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body develops and works, and they can shape how you respond to food, stress, and medications. More detail on this topic is available in the LearnHub.
Overview
PHLDA2Gene function
What if the gene works
The PHLDA2 gene helps control growth before birth, especially in the placenta. It helps keep placental growth in balance and supports how nutrients reach a growing baby.
Risk
What if the gene does not work
Changes affecting the PHLDA2 gene can disrupt placental growth control and influence fetal growth. Milder or more severe changes may contribute to lower birth weight and growth before birth, while reduced activity is linked with overgrowth in some imprinting conditions.
Treatment
What does that mean for your treatment
No PHLDA2-specific treatment or drug choice is currently established in clinical guidelines. The PHLDA2 gene is being studied mainly as a biomarker of placental function, fetal growth, and some cancers, rather than as a direct treatment target.
Gene function
What if the gene works
During pregnancy, the PHLDA2 gene helps the placenta grow in a balanced way. It is most active in placental tissue, where it supports the right mix of cell growth and cell specialization. This steady control helps the placenta work as an effective link between the pregnant parent and baby.
During pregnancy, the PHLDA2 gene helps keep placental growth in check. This steady control supports a placenta that is appropriately sized for its job.
It helps placental cells stop dividing at the right time and take on specialized roles. That balance supports normal placental structure and routine function.
By guiding how placental tissue develops, the PHLDA2 gene supports the placenta's handling of nutrients and stored energy. This helps maintain an efficient connection between the pregnant parent and baby.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the PHLDA2 gene often affect how much protein is made rather than changing the protein itself, because this gene is tightly controlled by imprinting, a switch that keeps one parental copy less active. Milder variants may slightly shift expression, while more severe variants, including loss-of-function changes in the active copy or nearby control regions, can markedly reduce or increase activity. This helps explain what happens if the PHLDA2 gene does not work properly at the cellular level.
How variants are linked to conditions
Current evidence on how PHLDA2 variants are linked to conditions is still developing. The PHLDA2 gene does not yet have a broadly confirmed link to a specific health condition, and interpretation of a variant usually depends on the full clinical picture. Anyone with a confirmed variant in the PHLDA2 gene should use guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen across the general population. Most do not directly affect health and simply reflect the natural diversity found among people. For many genes, having a variant associated with a condition points to a potential link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. Still, in some situations, a single well described variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to PHLDA2. In some families, risk can be shaped by the exact genetic change and which parent it was inherited from, because this gene is affected by normal parent-specific gene control. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of PHLDA2 variants
There is not yet a broadly confirmed, single Mendelian pattern for conditions caused specifically by variants in the PHLDA2 gene. In practice, how variants of the PHLDA2 gene are inherited can be harder to predict because PHLDA2 sits on chromosome 11, an autosome, but it is also an imprinted gene. That means you inherit one copy from each parent, yet the maternal copy is usually the active one and the paternal copy is usually switched down, so parent of origin can matter when a change is passed on.
What does my PHLDA2 result mean for my family?
There is not yet a broadly confirmed, single inheritance pattern tied to a specific condition for PHLDA2 that applies in a simple family-by-family way. If you have a PHLDA2 result and want to know what it could mean for relatives, the answer depends on the exact finding and the condition being evaluated.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for PHLDA2 variants uses DNA from a blood or saliva sample to look for changes in the PHLDA2 gene. Some labs also use methylation testing (a test of whether the gene is switched on or off in the usual pattern), because results in this region can depend on which parent the gene copy came from.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order testing just for the PHLDA2 gene. If there are unusual growth findings in pregnancy or early childhood, testing decisions are usually made with a doctor or genetic counselor and may look at a wider area of chromosome 11, not PHLDA2 alone.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they can tell you varies with the condition and the kind of variant present. Over time, how the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics is the field that examines how genetic differences affect a person’s response to medication. It explores connections between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes help shape how strongly a drug works and how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the PHLDA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are used, so questions about treatment, side effects, or changes in your health are best discussed with your doctor.
History
PHLDA2 came to attention in the 1990s during research on chromosome 11p15.5, a region already linked to Beckwith-Wiedemann syndrome and certain childhood cancers. Initially understood only through visible traits, later recognized as tied to a specific gene, PHLDA2 was first studied under the name TSSC3 as scientists searched for growth related genes in that area. Researchers then showed that the PHLDA2 gene is imprinted, meaning only one parental copy is normally active. From these first observations, research expanded steadily. Early mouse studies helped establish its place in the wider story of imprinting and fetal growth, and PHLDA2 remains part of that important chapter in human genetics.